| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ranbaxy Laboratories Limited (NSE: RANBAXY)
RANBAXY Technical Analysis
1
| As on N/A RANBAXY SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
RANBAXYSHARE Price
| Open | N/A | Change | Price | % |
| High | N/A | 1 Day | N/A | N/A |
| Low | N/A | 1 Week | N/A | N/A |
| Close | N/A | 1 Month | N/A | N/A |
| Volume | N/A | 1 Year | N/A | N/A |
| 52 Week High N/A | 52 Week Low N/A | ||||
NSE INDIA Most Active Stocks
| IDEA | 6.69 | 0.30% |
| GTLINFRA | 1.86 | -0.53% |
| KBCGLOBAL | 0.52 | 18.18% |
| RPOWER | 66.98 | -0.10% |
| YESBANK | 20.24 | 0.40% |
| RTNPOWER | 13.97 | -0.36% |
| SUZLON | 65.41 | 1.05% |
| STLTECH | 99.38 | 19.26% |
| JPPOWER | 17.69 | 0.11% |
| ONGC | 256.79 | 2.10% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
| BAJFINANCE | 938.00 | -89.95% |
| KARMAENG | 75.80 | -7.97% |
| ANTGRAPHIC | 1.28 | -7.25% |
| SONAMLTD | 46.60 | -5.59% |
| VIMTALABS | 485.70 | -5.48% |
| RCOM | 1.75 | -5.41% |
| SUPREMEENG | 1.96 | -5.31% |
| MTEDUCARE | 2.36 | -5.22% |
| CINEVISTA | 17.79 | -5.12% |
| LCCINFOTEC | 5.59 | -5.09% |
| RANBAXY Daily Charts |
RANBAXY Intraday Charts |
Whats New @ Bazaartrend |
RANBAXY Free Analysis |
|
|
RANBAXY Important Levels Intraday
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE | |
| RESISTANCE |
RANBAXY Target June 2025
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
RANBAXY Weekly Target
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
RANBAXY Target2025
| 4th UP Target | |
| 3rd UP Target | |
| 2nd UP Target | |
| 1st UP Target | |
| 1st DOWN Target | |
| 2nd DOWN Target | |
| 3rd DOWN Target | |
| 4th DOWN Target |
Ranbaxy Laboratories Limited ( NSE INDIA Symbol : RANBAXY )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RANBAXY Synopsis Technicals View
| 50 Day EMA |
N/A (Short Term) |
N/A | |
| 100 Day EMA | N/A (Mid Term) | N/A | |
| 200 Day EMA | N/A (Long Term) | N/A | |
| MACD (12 26 9) | N/A | N/A | |
| RSI (14) | N/A | N/A | |
| MFI (14) | N/A | N/A | |
| CCI (20) | N/A | N/A | |
| WILLIAM %R (14) | N/A | N/A | |
| ADX (14) | N/A | N/A | |
| PSAR | N/A | N/A | |
| 10 Day Avg Volume | N/A | ||
RANBAXY Other Details
| Segment | EQ | |
| Market Capital | 69707112448.00 | |
| Sector | Healthcare | |
| Industry | Drugs - Generic | |
| Offical website | > | |
RANBAXY Address
 |
Devika Tower 12th Floor New Delhi, 110019 India Phone: 91 11 2623 7508 Fax: 91 11 2622 5987 |
|
RANBAXY Latest News
RANBAXY Business Profile
Ranbaxy Laboratories Limited, a pharmaceutical company, engages in the manufacture, marketing, and sale of pharmaceuticals products. It offers generic pharmaceuticals, branded generics, active pharmaceutical ingredients and intermediates, anti-retrovirals, and over-the-counter products. The companyÂ’s products are used for the treatment of chronic and lifestyle diseases in the areas of cardiovascular, central nervous system, respiratory, dermatology, orthopedics, nutritional, and urology, as well as in the areas of gastroenterology, anti-infectives, pain and musculoskeletal, and endocrine and metabolic. It operates primarily in India, Europe, North America, the Asia Pacific, and Africa. The company was founded in 1961 and is headquartered in New Delhi, India. Ranbaxy Laboratories Limited is a subsidiary of Daiichi Sankyo Company, Ltd.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service